CUREDUCHENNE VENTURES
CUREDUCHENNE VENTURES
Status:
Active
Current Employees Featured
Debra Miller
Debra Miller CEO @ CureDuchenne Ventures CEO
Bradley L Hodges
Bradley L Hodges Partner @ CureDuchenne Ventures Partner 2022-05-01
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-06-07 | Code Biotherapeutics | CureDuchenne Ventures investment in Series A - Code Biotherapeutics | 75 M USD |
2021-12-22 | Gennao Bio | CureDuchenne Ventures investment in Series A - Gennao Bio | 1000 K USD |
2021-08-05 | Pepgen | CureDuchenne Ventures investment in Venture Round - Pepgen | 112.5 M USD |
2021-04-20 | Code Biotherapeutics | CureDuchenne Ventures investment in Seed Round - Code Biotherapeutics | 10 M USD |
2021-03-31 | Entrada Therapeutics | CureDuchenne Ventures investment in Series B - Entrada Therapeutics | 116 M USD |
2020-12-09 | Pepgen | CureDuchenne Ventures investment in Series A - Pepgen | 45 M USD |
2020-12-08 | Edgewise Therapeutics | CureDuchenne Ventures investment in Series C - Edgewise Therapeutics | 95 M USD |
2020-11-10 | Mesentech | CureDuchenne Ventures investment in Venture Round - Mesentech | N/A |
2020-04-23 | Myosana Therapeutics | CureDuchenne Ventures investment in Seed Round - Myosana Therapeutics | 1000 K USD |
2019-11-13 | Avidity Biosciences | CureDuchenne Ventures investment in Series C - Avidity Biosciences | 100 M USD |
Key Employee Changes
Date | New article |
---|---|
2022-05-13 | Cureduchenne Strengthens Research and Investment Team With Addition of Vice President of Research and Partner of CureDuchenne Ventures |